{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:19:52Z","timestamp":1793834392881,"version":"4.6.1"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T00:00:00Z","timestamp":1565308800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"},{"start":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T00:00:00Z","timestamp":1565308800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jsm.jsexmed.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,9,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Current treatment guidelines for adolescents with gender dysphoria recommend therapy with gonadotropin-releasing hormone agonists (GnRHa) and testosterone in transgender males. However, most evidence on the safety and efficacy of testosterone is based on studies in adults.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Aim<\/jats:title>\n                  <jats:p>This study aimed to investigate the efficacy and safety of testosterone treatment in transgender adolescents.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>The study included 62 adolescents diagnosed with gender dysphoria who had started GnRHa treatment and had subsequently received testosterone treatment for more than 6 months.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Main Outcome Measure<\/jats:title>\n                  <jats:p>Virilization, anthropometry, laboratory parameters, and bone mineral density (BMD) were analyzed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Adolescents were treated with testosterone for a median duration of 12 months. Voice deepening began within 3 months in 85% of adolescents. Increased hair growth was first reported on the extremities, followed by an increase of facial hair. Acne was most prevalent between 6 and 12 months of testosterone therapy. Most adolescents had already completed linear growth; body mass index and systolic blood pressure increased but diastolic blood pressure did not change. High-density lipoprotein (HDL) cholesterol and sex hormone binding globulin significantly decreased, but hematocrit, hemoglobin, prolactin, androstenedione, and dehydroepiandrosterone sulfate significantly increased, although not all changes were clinically significant. Other lipids and HbA1c did not change. Vitamin D deficiency was seen in 32\u201354% throughout treatment. BMD z-scores after 12 to 24 months of testosterone treatment remained below z-scores before the start of GnRHa treatment.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Clinical Implications<\/jats:title>\n                  <jats:p>Adolescents need to be counseled about side effects with potential longer term implications such as increased hematocrit and decreased HDL cholesterol and decreased BMD z-scores. They should be advised on diet, including adequate calcium and vitamin D intake; physical exercise; and the use of tobacco and alcohol to avoid additional risk factors for cardiovascular disease and osteoporosis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Strengths &amp; Limitations<\/jats:title>\n                  <jats:p>Strengths are the standardized treatment regimen and extensive set of safety parameters investigated. Limitations are the limited duration of follow-up and lack of a control group so some of the observed changes may be due to normal maturation rather than to treatment.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Testosterone effectively induced virilization beginning within 3 months in the majority of adolescents. Acne was a common side effect, but no short-term safety issues were observed. The increased hematocrit, decreased HDL cholesterol, and decreased BMD z-scores are in line with previous studies. Further follow-up studies will need to establish if the observed changes result in adverse outcomes in the long term.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1016\/j.jsxm.2019.06.014","type":"journal-article","created":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T21:09:41Z","timestamp":1565384981000},"page":"1459-1468","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":89,"title":["Physical Changes, Laboratory Parameters, and Bone Mineral Density During Testosterone Treatment in Adolescents with Gender Dysphoria"],"prefix":"10.1093","volume":"16","author":[{"given":"Iris E.","family":"Stoffers","sequence":"first","affiliation":[{"name":"Department of Pediatrics , Leiden , the Netherlands"},{"name":"Leiden University Medical Centre , Leiden , the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine C.","family":"de Vries","sequence":"additional","affiliation":[{"name":"Department of Pediatrics , Leiden , the Netherlands"},{"name":"Leiden University Medical Centre , Leiden , the Netherlands"},{"name":"Department of Medical Ethics and Health Law , Leiden , the Netherlands"},{"name":"Leiden University Medical Centre , Leiden , the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine E.","family":"Hannema","sequence":"additional","affiliation":[{"name":"Department of Pediatrics , Leiden , the Netherlands"},{"name":"Leiden University Medical Centre , Leiden , the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,8,9]]},"reference":[{"key":"2023010721202420700_bib1","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.jsxm.2018.01.016","article-title":"The Amsterdam Cohort of Gender Dysphoria Study (1972-2015): trends in prevalence, treatment, and regrets","volume":"15","author":"Wiepjes","year":"2018","journal-title":"J Sex Med"},{"key":"2023010721202420700_bib2","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1542\/peds.2013-2958","article-title":"Young adult psychological outcome after puberty suppression and gender reassignment","volume":"134","author":"de Vries","year":"2014","journal-title":"Pediatrics"},{"key":"2023010721202420700_bib3","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jadohealth.2014.10.275","article-title":"Does it get better? A longitudinal analysis of psychological distress and victimization in lesbian, gay, bisexual, transgender, and questioning youth","volume":"56","author":"Birkett","year":"2015","journal-title":"J Adolesc Health"},{"key":"2023010721202420700_bib4","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1210\/jc.2017-01658","article-title":"Endocrine treatment of gender-dysphoric\/gender-incongruent persons: an Endocrine Society Clinical Practice Guideline","volume":"102","author":"Hembree","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"2023010721202420700_bib5","first-page":"2356","article-title":"Efficacy and safety of pubertal induction using 17\u03b2-estradiol in transgirls","volume":"102","author":"Hannema","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"2023010721202420700_bib6","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13293-016-0067-9","article-title":"Consecutive lynestrenol and cross-sex hormone treatment in biological female adolescents with gender dysphoria: a retrospective analysis","volume":"7","author":"Tack","year":"2016","journal-title":"Biol Sex Differ"},{"key":"2023010721202420700_bib7","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jsxm.2017.12.009","article-title":"Early hormonal treatment affects body composition and body shape in young transgender adolescents","volume":"15","author":"Klaver","year":"2018","journal-title":"J Sex Med"},{"key":"2023010721202420700_bib8","doi-asserted-by":"crossref","first-page":"e155","DOI":"10.1111\/pde.13448","article-title":"Transgender adolescents and acne: a cases series","volume":"35","author":"Campos-Munoz","year":"2018","journal-title":"Pediatr Dermatol"},{"key":"2023010721202420700_bib9","doi-asserted-by":"crossref","first-page":"3914","DOI":"10.1210\/jc.2017-01643","article-title":"Sex steroids and cardiovascular outcomes in transgender individuals: a systematic review and meta-analysis","volume":"102","author":"Maraka","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"2023010721202420700_bib10","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/andr.12382","article-title":"Effects of testosterone therapy on BMI, blood pressure, and laboratory profile of transgender men: a systematic review","volume":"5","author":"Velho","year":"2017","journal-title":"Andrology"},{"key":"2023010721202420700_bib11","doi-asserted-by":"crossref","first-page":"e20163173","DOI":"10.1542\/peds.2016-3173","article-title":"Cross-sex hormones and metabolic parameters in adolescents with gender dysphoria","volume":"139","author":"Jarin","year":"2017","journal-title":"Pediatrics"},{"key":"2023010721202420700_bib12","doi-asserted-by":"crossref","first-page":"E270","DOI":"10.1210\/jc.2014-2439","article-title":"Bone mass in young adulthood following gonadotropin-releasing hormone analog treatment and cross-sex hormone treatment in adolescents with gender dysphoria","volume":"100","author":"Klink","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"2023010721202420700_bib13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.bone.2016.11.008","article-title":"Effect of pubertal suppression and cross-sex hormone therapy on bone turnover markers and bone mineral apparent density (BMAD) in transgender adolescents","volume":"95","author":"Vlot","year":"2017","journal-title":"Bone"},{"key":"2023010721202420700_bib14","article-title":"Diagnostic and statistical manual of mental disorders","author":"APA","year":"2018","edition":"fifth ed."},{"key":"2023010721202420700_bib15","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/pr.2012.189","article-title":"The world\u2019s tallest nation has stopped growing taller: the height of Dutch children from 1955 to 2009","volume":"73","author":"Schonbeck","year":"2013","journal-title":"Pediatr Res"},{"key":"2023010721202420700_bib16","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1136\/bmj.320.7244.1240","article-title":"Establishing a standard definition for child overweight and obesity worldwide: international survey","volume":"320","author":"Cole","year":"2000","journal-title":"BMJ"},{"key":"2023010721202420700_bib17","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1210\/jc.2006-2553","article-title":"The bone mineral density in childhood study: bone mineral content and density according to age, sex, and race","volume":"92","author":"Kalkwarf","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2023010721202420700_bib18","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1136\/adc.2006.097642","article-title":"UK reference data for the Hologic QDR Discovery dual-energy x-ray absorptiometry scanner in healthy children and young adults aged 6-17 years","volume":"92","author":"Ward","year":"2007","journal-title":"Arch Dis Child"},{"key":"2023010721202420700_bib19","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/jsm.12366","article-title":"Short- and long-term clinical skin effects of testosterone treatment in trans men","volume":"11","author":"Wierckx","year":"2014","journal-title":"J Sex Med"},{"key":"2023010721202420700_bib20","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s00405-015-3846-8","article-title":"Voice deepening under testosterone treatment in female-to-male gender dysphoric individuals","volume":"273","author":"Deuster","year":"2016","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"2023010721202420700_bib21","doi-asserted-by":"crossref","first-page":"766.e23","DOI":"10.1016\/j.jvoice.2015.10.016","article-title":"Effects on voice fundamental frequency and satisfaction with voice in trans men during testosterone treatment-a longitudinal study","volume":"30","author":"Nygren","year":"2016","journal-title":"J Voice"},{"key":"2023010721202420700_bib22","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jadohealth.2017.08.005","article-title":"Physiologic response to gender-affirming hormones among transgender youth","volume":"62","author":"Olson-Kennedy","year":"2018","journal-title":"J Adolesc Health"},{"key":"2023010721202420700_bib23","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1210\/jc.2018-00229","article-title":"Testosterone therapy in men with hypogonadism: an Endocrine Society Clinical Practice Guideline","volume":"103","author":"Bhasin","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"2023010721202420700_bib24","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1365-2265.1995.tb02611.x","article-title":"Effects of gonadal androgens and oestrogens on adrenal androgen levels","volume":"43","author":"Polderman","year":"1995","journal-title":"Clin Endocrinol"},{"key":"2023010721202420700_bib25","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1210\/jcem-72-5-1025","article-title":"The effects of prolonged hypertestosteronemia on adrenocortical biosynthesis in oophorectomized women","volume":"72","author":"Azziz","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"2023010721202420700_bib26","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.jsxm.2018.07.017","article-title":"Changes in adrenal androgens during puberty suppression and gender-affirming hormone treatment in adolescents with gender dysphoria","volume":"15","author":"Schagen","year":"2018","journal-title":"J Sex Med"},{"key":"2023010721202420700_bib27","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1677\/joe.0.1590373","article-title":"Evidence for androgen receptor gene expression and growth inhibitory effect of dihydrotestosterone on human adrenocortical cells","volume":"159","author":"Rossi","year":"1998","journal-title":"J Endocrinol"},{"key":"2023010721202420700_bib28","doi-asserted-by":"publisher","DOI":"10.1111\/and.12666","article-title":"Prolactin levels during short- and long-term cross-sex hormone treatment: an observational study in transgender persons","volume":"49","author":"Nota","year":"2017","journal-title":"Andrologia"},{"key":"2023010721202420700_bib29","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/oxfordjournals.humrep.a137410","article-title":"Experience with a depot GnRH-agonist (Zoladex) in the treatment of genital endometriosis","volume":"6","author":"Mettler","year":"1991","journal-title":"Hum Reprod"},{"key":"2023010721202420700_bib30","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1365-2265.2006.02642.x","article-title":"Oestradiol stimulates prolactin secretion in women through oestrogen receptors","volume":"65","author":"Garas","year":"2006","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609519312731?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609519312731?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/16\/9\/1459\/48477034\/jsm_16_9_1459.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/16\/9\/1459\/48477034\/jsm_16_9_1459.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,7]],"date-time":"2023-01-07T21:21:41Z","timestamp":1673126501000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/16\/9\/1459\/6966844"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,9]]},"references-count":30,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2019,8,9]]},"published-print":{"date-parts":[[2019,9,1]]}},"URL":"https:\/\/doi.org\/10.1016\/j.jsxm.2019.06.014","relation":{},"ISSN":["1743-6109","1743-6095"],"issn-type":[{"value":"1743-6109","type":"electronic"},{"value":"1743-6095","type":"print"}],"subject":[],"published-other":{"date-parts":[[2019,9]]},"published":{"date-parts":[[2019,8,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Physical changes, laboratory parameters, and bone mineral density during testosterone treatment in adolescents with gender dysphoria","name":"articletitle","label":"Article Title"},{"value":"The Journal of Sexual Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsxm.2019.06.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 International Society for Sexual Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}